In this study, for the first time, we report five oncogenes (TUBA1B, SLC2A1, PGK1, CCND1, and NCAPD2) and two tumor suppressors’ genes (RPLP2, RPL37) as novel therapeutic targets in breast cancer. This evidence concerns the gene PGK1 and breast carcinoma.